Financial News
EU medicines regulator says benefits of J&J vaccine outweigh risks as it reviews rare blood clots
April 14, 2021 at 09:59 AM EDT
Europe's medicines regulator on Wednesday said it still believes the benefits of Johnson & Johnson's Covid-19 vaccine outweigh the risks of side effects.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
